Fundz

Schneider Electric to acquire PTC for $205 per share

PRIVATEOct 05, 2026

Acquiring Company

Schneider Electric

Acquired Company

PTC Therapeutics

Ile De FranceSouth PlainfieldEnergyOil And GasRenewable EnergyEnergy ManagementBiotechnology

Description

Schneider Electric has announced an agreement to acquire PTC Inc. in an all-cash deal valued at $205 per share. Following the announcement, shares of PTC saw a surge of over 33%. This acquisition aims to enhance Schneider Electric's capabilities in product lifecycle management and industrial IoT.

Company Information

Company

Schneider Electric

Location

Ile De France, France

About

Schneider Electric is a multinational corporation specializing in energy management and automation solutions. The company focuses on digital transformation of energy management and automation in homes, buildings, data centers, infrastructure, and industries. Schneider Electric is committed to sustainability and innovation. With a global presence, it serves customers in over 100 countries.

Fundz sees it the moment Schneider Electric makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Schneider Electric's next move

Learn about Strategic plan

Frequently asked

Who acquired PTC Therapeutics?

PTC Therapeutics was acquired by Schneider Electric, based in Ile De France. The deal was reported on October 5, 2026. Schneider Electric is a multinational corporation specializing in energy management and automation solutions. Schneider Electric is privately held and operates in Energy.

When did Schneider Electric acquire PTC Therapeutics?

Schneider Electric's acquisition of PTC Therapeutics was reported on October 5, 2026. Schneider Electric has announced an agreement to acquire PTC Inc. in an all-cash deal valued at $205 per share. Following the announcement, shares of PTC saw a surge of over 33%. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does PTC Therapeutics do?

PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs. It is publicly traded (PTCT), operating in Biotechnology, and is based in South Plainfield.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.